The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies
Journal Title: Global Journal of Allergy - Year 2017, Vol 3, Issue 1
Abstract
Background: Cysteinyl leukotriene levels are elevated in patients with atopic dermatitis, which can lead to eosinophilic infiltration of the gastrointestinal tract. Objective: We examined the role that montelukast (a leukotriene receptor antagonist) might play in improving symptoms of atopic dermatitis induced by food allergies. Methods: We conducted a randomized, double-blind, placebo-controlled, parallel group study in 20 children, aged 1 to 8 years, with 4 study visits every 3 weeks for 9 weeks. Primary inclusion criteria consisted of: 1) positive reactivity to food (indicated by skin or RAST test); 2) 10–25 % body area affected with atopic dermatitis; and 3) gastrointestinal symptoms. Liquid cetirizine and 1% hydrocortisone cream were both given as rescue medications for atopic dermatitis flare-ups. Pruritis and atopic dermatitis flare-up scores were used to collect clinical data. Laboratory values for nerve growth factor were evaluated pre- and post-treatment. Results: Our main endpoints were the effects of montelukast on the clinical presentation of atopic dermatitis. When comparing the treatment group to placebo, we noted a significant reduction in the pruritis score (p=0.002); a trend toward a reduction in the use of rescue medication (cetirizine: p=0.056; hydrocortisone cream: p=0.056); and a reduction in the level of nerve growth factor; mean values: placebo=3.06 to montelukast=2.59. Conclusion: The inflammatory pathway triggered by food allergies that may lead to atopic dermatitis can be modulated with montelukast. Furthermore, nerve growth factor may play a role in the pathogenesis of atopic dermatitis and montelukast may modify this pathway.
Authors and Affiliations
Melamed Isaac, Robinson Lacey, Heffron Melinda
Keywords
Related Articles
- EP ID EP342765
- DOI 10.17352/2455-8141.000018
- Views 80
- Downloads 0
Inhibition of Interleukin-4 Signalling in the Treatment of Atopic Dermatitis and Allergic Asthma
Atopic dermatitis and allergic asthma result from amplified immune response to environmental antigens, and allergic reactions from released IgE, histamine, leukotrienes and cytokines. Environmental antigens immune cells,...
Nocturnal Asthma: A Special Type of Asthma
Nocturnal asthma is defined by a drop in forced expiratory volume in 1 second (FEV1) of at least 15% between bedtime and awakening in patients with clinical and physiologic evidence of asthma. Nocturnal asthma is associa...
The Benefit of Montelukast in Atopic Dermatitis Induced by Food Allergies
Background: Cysteinyl leukotriene levels are elevated in patients with atopic dermatitis, which can lead to eosinophilic infiltration of the gastrointestinal tract. Objective: We examined the role that montelukast (a le...
Polyphenols and their Mechanism of Action in Allergic Immune Response
Mini review article deals with the most studied group of chemical compounds – polyphenols – predominantly flavonoids in relation to their allergic immune response. There is clarified and discussed their mechanism of acti...
In 250 Children we Demonstrate that the Transmission of Allergy and Asthma is Chiefly Genetic, Mainly when these Children are Asthmatic
There seems to be no unanimity of opinion as to the mode of transmission of allergic disease. According to some, allergy is transmitted as a simple Mendelian dominant. In direct contrast, others maintain that the finding...